Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Toripalimab”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04731909
What this trial is testing

Toripalimab Combined With Anlotinib, Etoposide and Platinum in the Treatment of Extensive-stage Small Cell Lung Cancer

Who this might be right for
SCLC, Extensive StageLung CancerSmall Cell Lung Cancer
Third Military Medical University 80
Early research (Phase 1)Study completedNCT05040932
What this trial is testing

Study of YH004 (4-1BB Agonist Antibody) in Advanced or Metastatic Malignancy

Who this might be right for
Cancer
Eucure (Beijing) Biopharma Co., Ltd 8
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07279597
What this trial is testing

A Phase II Study of Toripalimab Plus RC48-ADC With Radiotherapy for Bladder Preservation in HER2-Positive Muscle-Invasive Bladder Cancer

Who this might be right for
Muscle-invasive Bladder Urothelial Carcinoma
Tongji Hospital 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07493980
What this trial is testing

Study on the Efficacy and Safety of JSKN016 as Neoadjuvant Therapy in Resectable Stage II-III Non-small Cell Lung Cancer Patients

Who this might be right for
NSCLC Stage II
Shanghai Pulmonary Hospital, Shanghai, China 54
Testing effectiveness (Phase 2)UnknownNCT03811379
What this trial is testing

Toripalimab as Monotherapy for Patients With Small Cell Carcinoma of Esophagus Who Failed Chemotherapy

Who this might be right for
Small Cell Carcinoma of EsophagusAdvanced Cancer
Sun Yat-sen University 43
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06279403
What this trial is testing

Upfront Immune Checkpoint Inhibitors With Deferred Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma

Who this might be right for
Clear-cell Metastatic Renal Cell CarcinomaImmune Checkpoint InhibitorsCytoreductive Nephrectomy
RenJi Hospital 20
Testing effectiveness (Phase 2)WithdrawnNCT05212922
What this trial is testing

Evaluate YH001 in Combination With Toripalimab in Subjects With Advanced NSCLC and HCC

Who this might be right for
HCCNSCLC Stage IIIBNSCLC Stage IV
Eucure (Beijing) Biopharma Co., Ltd
Testing effectiveness (Phase 2)UnknownNCT04278222
What this trial is testing

Anlotinib Plus Toripalimab as First-line Treatment for Advanced Gastric Cancer With ECOG 2 (APICAL-GC)

Who this might be right for
Gastric CancerImmunotherapyAnlotinib+1 more
Shanghai Changzheng Hospital 24
Testing effectiveness (Phase 2)Looking for participantsNCT07571551
What this trial is testing

Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell RCC
Jinling Hospital, China 75
Early research (Phase 1)Study completedNCT04640545
What this trial is testing

Assess LBL-007 in Combination With Toripalimab and Axitinib Tablets Subjects With Advanced Melanoma

Who this might be right for
Advanced Melanoma
Nanjing Leads Biolabs Co.,Ltd 79
Testing effectiveness (Phase 2)UnknownNCT04058470
What this trial is testing

Toripalimab Plus Rituximab Followed by R-CHOP for Elderly Patients With Untreated Diffused B Cell Lymphoma

Who this might be right for
Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaFollicular Lymphoma Grade IIIb+3 more
Huiqiang Huang 140
Early research (Phase 1)Study completedNCT04374877
What this trial is testing

Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorClear Cell Renal Cell CarcinomaHepatocellular Carcinoma+1 more
Coherus Oncology, Inc. 145
Testing effectiveness (Phase 2)Looking for participantsNCT07088211
What this trial is testing

Sacituzumab Tirumotecan and Toripalimab in the First-line Treatment of HNSCC

Who this might be right for
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 39
Testing effectiveness (Phase 2)UnknownNCT04713761
What this trial is testing

Neoadjuvant Toripalimab Combined With Chemotherapy in the Treatment of Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Shanghai Pulmonary Hospital, Shanghai, China 15
Large-scale testing (Phase 3)Study completedNCT04158440
What this trial is testing

Phase III Study of Toripalimab Versus Placebo Plus Chemotherapy in Resectable NSCLC

Who this might be right for
Stage II-III Non-small Cell Lung Cancer
Shanghai Junshi Bioscience Co., Ltd. 501
Testing effectiveness (Phase 2)Looking for participantsNCT04807140
What this trial is testing

Neoadjuvant Toripalimab or Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated HNSCC (HNSCC-002)

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 57
Not applicableNot Yet RecruitingNCT07308379
What this trial is testing

Real-World Study of Toripalimab in Extensive-Stage Small Cell Lung Cancer

Who this might be right for
SCLC, Extensive StageToripalimab
Fudan University 1,200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07412171
What this trial is testing

NECTAR Study: Neoadjuvant Toripalimab + 9MW2821 for Local UTUC

Who this might be right for
Upper Tract Urothelial Carcinoma
Peking University Third Hospital 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06283121
What this trial is testing

A Clinical Study of BioTTT001 in Combination With SOX and Toripalimab in Patients With Gastric Cancer

Who this might be right for
Gastric Cancer, Metastatic
China Medical University, China 30
Testing effectiveness (Phase 2)Looking for participantsNCT06964906
What this trial is testing

Neoadjuvant High-Intensity Focused Ultrasound (HIFU) Combined With Toripalimab and Chemotherapy for ER-Positive /HER2-Negative Breast Cancer

Who this might be right for
ER+/HER2- Breast Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 30
Next Page